Hoth Therapeutics Inc., a patient-focused biopharmaceutical company, has enhanced its intellectual property portfolio by acquiring and expanding patent applications to its therapeutic pipeline. These newly secured patents reflect Hoth’s commitment to pioneering treatments that address unmet medical needs, with a focus on enhancing therapeutic efficacy and broadening applications across various disease areas. “Our expanding intellectual property portfolio supports Hoth’s p...